Skip to content

Application of Jintiange in osteoporotic distal radius fractures

Application of Jintiange in osteoporotic distal radius fractures

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2200006870
Enrollment
Unknown
Registered
2022-12-16
Start date
2023-01-01
Completion date
Unknown
Last updated
2023-03-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

osteoporotic distal radius fractures

Interventions

Experimental group:Basic treatment + Jintiange Capsules
Control group:Basic treatment

Sponsors

The Second Affiliated Hospital of Anhui Medical University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: (1) Meeting the criteria for the diagnosis of osteoporosis as described above. (2) Aged 60 years or older. (3) No serious cardiovascular, cerebrovascular, hepatic or renal, or psychiatric diseases. (4) X-rays showing a distal radius fracture. (5) The distal radius fracture can be functionally repositioned by manipulation. (6) Can take the test drug for a long period of time and will not interrupt the drug on their own. (7) They are able to understand the study well and voluntarily join. Translated with www.DeepL.com/Translator (free version)

Exclusion criteria

Exclusion criteria: (1) Those who do not meet the above diagnostic criteria and inclusion criteria. (2) Those who are allergic and cannot take the tested drugs. (3) Those who have taken drugs affecting bone conversion such as glucocorticoids within 3 months (4) pathological osteoporosis caused by bone tumors, bone tuberculosis, etc. (5) Those with cardiac, hepatic or renal insufficiency, and those with severe cardiovascular disease. (6) taking drugs that can cause adverse reactions with the test drug and cannot be stopped in the short term (7) Those who suffer from serious mental disorders and cannot cooperate to complete the test. Translated with www.DeepL.com/Translator (free version)

Design outcomes

Primary

MeasureTime frame
Fracture healing;

Countries

China

Contacts

Public ContactJun Li
efylijunpaper@163.com13721052626

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026